Skylight Health Announces Series A Preferred Stock Cash Dividend
February 16 2022 - 5:00PM
Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG)
(“Skylight Health” or the “Company”), a multi-state primary care
management group in the United States, announced that its Board of
Directors has authorized, and the Company has declared, a dividend
on its 9.25% Series A Cumulative Redeemable Perpetual Preferred
Shares (the “Series A Preferred Shares”) for the month of March
2022. The Series A Preferred Shares trade under the “SLHGP” stock
ticker symbol.
In accordance with the terms of the Series A Preferred Shares,
the Series A dividend will be payable in cash in the amount of
$0.1927 per share on March 21, 2022 to the shareholders of record
of the Series A Preferred Stock as of the dividend record date of
February 28, 2022.
The Company is also announcing the issuance of 317,759 shares
related to its previously announced acquisition of River City
Medical Associates announced on February 4, 2021. All issued shares
will be subject to a four-month hold from the date of issuance and
is subject to TSX-V approval.
About Skylight Health Group
Skylight Health is a healthcare services and technology company,
working to positively impact patient health outcomes. The Company
operates a US multi-state primary care health network comprised of
physical practices providing a range of services from primary care,
sub-specialty, allied health, and laboratory/diagnostic testing.
The Company is focused on helping small and independent practices
shift from a traditional fee-for-service (FFS) model to value-based
care (VBC) through tools including proprietary technology, data
analytics and infrastructure. In an FFS model, payors (commercial
and government insurers) reimburse on an encounter-based approach.
This puts a focus on volume of patients per day. In a VBC model,
the providers offer care that is aimed at keeping patients healthy
and minimize unnecessary health expenditures that are not proven to
maintain the patient’s well-being. This places an emphasis on
quality over volume. VBC will lead to improved patient outcomes,
reduced cost of delivery and drive stronger financial performance
from existing practices.
Forward Looking Statements
This press release may include predictions, estimates or other
information that might be considered forward-looking within the
meaning of applicable securities laws. While these forward-looking
statements represent our current judgments, they are subject to
risks and uncertainties that could cause actual results to differ
materially. You are cautioned not to place undue reliance on these
forward-looking statements, which reflect our opinions only as of
the date of this release. Please keep in mind that we are not
obligating ourselves to revise or publicly release the results of
any revision to these forward-looking statements in light of new
information or future events. When used herein, words such as "look
forward," "believe," "continue," "building," or variations of such
words and similar expressions are intended to identify
forward-looking statements. Factors that could cause actual results
to differ materially from those contemplated in any forward-looking
statements made by us herein are often discussed in filings we make
with the Canadian and United States securities regulators,
including the Securities and Exchange Commission, available
at: www.sec.gov, and Canadian Securities
Administrators, available at www.sedar.com,
and on our website,
at skylighthealthgroup.com.
For more information, please visit our website or contact:
Investor Relations: Jackie
Kelly investors@skylighthealthgroup.com 416-301-2949
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Skylight Health (NASDAQ:SLHGP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Skylight Health (NASDAQ:SLHGP)
Historical Stock Chart
From Sep 2023 to Sep 2024